tiprankstipranks
Trending News
More News >
Vertex Pharmaceuticals Inc. (DE:VX1)
:VX1

Vertex Pharmaceuticals (VX1) Revenue

Compare
23 Followers

Vertex Pharmaceuticals Revenue

Vertex Pharmaceuticals had a revenue of 3.08B in the quarter ending Sep 30, 2025, with 3.77%. This bring the company's revenue in the last twelve months to 11.72B, Decreased 2.67%. In the fiscal year ending Dec 31, 2024, Vertex Pharmaceuticals had annual revenue of 11.02B with 11.66% growth.
Revenue (ttm)
11.72B
Revenue Growth
P/S Ratio
8.97
Revenue/Employee
€1,806,574
Employees
6,100
Market Cap
€98.82B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
11.02B1.15B+111.66%
Dec 31, 2023
9.87B938.50M+110.51%
Dec 31, 2022
8.93B1.36B+117.91%
Dec 31, 2021
7.57B1.37B+122.06%
Dec 31, 2020
6.21B2.04B+149.07%
Dec 31, 2019
4.16B1.12B+136.59%
Dec 31, 2018
3.05B558.95M+122.46%
Dec 31, 2017
2.49B786.48M+146.20%
Dec 31, 2016
1.70B